The company’s Repatha (evolocumab) was added to optimised statin therapy in a phase 3 trial, and resulted in statistically significant regression of atherosclerosis in patients with coronary ...
Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.
Repatha (evolocumab) is a prescription drug used in certain situations to lower cholesterol and reduce serious heart-related risks. Repatha does this by attaching itself to a protein in your body ...
She prescribed Repatha injections instead. They control my cholesterol without causing extreme pain. I am grateful. A. Almost a decade ago, the FDA approved two new drugs to lower LDL cholesterol.
Product sales were also up 22%. Sales of Repatha, Amgen’s cholesterol drug, increased 33% year over year to $517 million, the company said. Its Prolia osteoporosis drug generated sales of $999 ...
Hosted on MSN1mon
Most of Wall Street rises as earnings reporting season ramps upIt reported stronger profit for the latest quarter than expected, thanks in part to growth for its Repatha medicine, which can lower bad cholesterol and reduce the risk of heart attack.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback